favipiravir - living meta-analysis of clinical studies

table network network 2

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study

	COVID-19 severe or critically

	COVID-19 severe or critically
favipiravir	Kocayigit H

3 studies excluded by filtering options 2

6184	Erdem, 2020	2	11	0	excluded	not a RCT	risk of bias not avaialble
6262	Yamamura, 2020	2	30	0	excluded	not a RCT	risk of bias not avaialble
6267	Murohashi, 2020	2	10	0	excluded	not a RCT	risk of bias not avaialble